

N-acetyl cysteine (NAC) is an FDA-approved drug clinically applied on a broad range of pathologies. Further research has been conducted with this drug to benefit from its antimicrobial activity potential. However, NAC has a very short half-life and therefore strategies that accomplish high local concentrations would be beneficial. In this study, covalent immobilization of NAC was performed, in order to obtain long-lasting high local concentration of the drug onto a chitosan(Ch)-derived implant-related coating. For the development of NAC-functionalized Ch films, water-based carbodiimide chemistry was applied to avoid the use of toxic organic solvents. Here we report the optimization steps performed to immobilize NAC onto the surface of pre-prepared Ch coatings, to ensure full exposure of NAC. Surface characterization using ellipsometry, water contact angle measurements and X-ray photoelectron spectroscopy (XPS), demonstrated the success of NAC immobilization at 4 mg/mL. Quartz crystal microbalance with dissipation (QCM-D) demonstrated that surface immobilized NAC decreases protein adsorption to Ch coatings. Biological studies confirmed that immobilized NAC4 avoids methicillin-resistant Staphylococcus aureus adhesion to Ch coating, impairing biofilm formation, without inducing cytotoxic effects. This is particularly interesting towards further developments as a prevention coating. © 2017 The Author(s).
| EMTREE drug terms: | acetylcysteinebiocompatible coated materialchitosan |
|---|---|
| EMTREE medical terms: | bacterium adherencebiofilmchemistrydrug effectmaterials testingmethicillin resistant Staphylococcus aureusphysiologysurface property |
| MeSH: | AcetylcysteineBacterial AdhesionBiofilmsChitosanCoated Materials, BiocompatibleMaterials TestingMethicillin-Resistant Staphylococcus aureusSurface Properties |
acetylcysteine, 616-91-1; chitosan, 9012-76-4;
Acetylcysteine; Chitosan; Coated Materials, Biocompatible
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| COMPETE | ||
| Fundação para a Ciência e a Tecnologia See opportunities | UID/Multi/04378/2013 | |
| POCI | ||
| NORTE-01-0145-FEDER-000012,Norte-01-0145-FEDER-000024,POCI-01-0145-FEDER-007274 |
This work was financed by FEDER funds through COMPETE 2020 (POCI), Portugal 2020 and FCT/MCTES through POCI-01-0145-FEDER-007274; NORTE-01-0145-FEDER-000012; Norte-01-0145-FEDER-000024 and FCT grants UID/Multi/04378/2013.
Martins, M.C.L.; I3S, Instituto de Investigação e Inovação em Saúde, Universidade Do Porto, Rua, Portugal;
© Copyright 2017 Elsevier B.V., All rights reserved.